Taking a GLP-1 With ADHD Stimulants: Appetite, Heart Rate, and What to Tell Your Prescribers

You can take a GLP-1 medication and an ADHD stimulant at the same time, and many people do. There's no listed drug interaction between them in the FDA labels. But the two drug types share effects: both reduce appetite, both nudge heart rate up a little, and one changes how fast your stomach empties, which can affect how the other is absorbed. None of that makes the combination off-limits. It does mean your prescribers should know the full picture and you should watch a few specific things.

This article doesn't give dosing advice for either drug. Dose decisions belong to the clinician who prescribes each one.

What the FDA labels say about the combination

The Wegovy prescribing information lists two drug-interaction categories: insulin or sulfonylureas (because of low blood sugar risk) and oral medications in general (because semaglutide delays gastric emptying). The Zepbound label says the same about oral medications and adds specific guidance for oral contraceptives. Neither names stimulants.

The Adderall XR label, revised April 2026, doesn't list GLP-1 drugs either. Its interaction section focuses on MAO inhibitors, serotonergic drugs, and agents that change stomach or urine acidity.

"Not listed" isn't the same as "studied and found safe." It means no one has identified a specific pharmacological interaction. The combination simply hasn't been the subject of a dedicated trial, so the practical concerns come from what each drug does on its own.

Appetite suppression stacking

This is the most common real-world issue. Stimulants reduce appetite. In the Adderall XR clinical trials, decreased appetite was reported by 33% of adults (versus 3% on placebo), 36% of adolescents, and 22% of children, and weight loss was reported in 10% of adults. GLP-1 drugs reduce appetite through a different route, by acting on the brain's satiety signals and slowing digestion.

Put those together and some people find they're barely eating, especially at midday when a morning stimulant dose is at its peak. That's a problem for a few reasons:

• Protein and muscle. Weight loss on GLP-1s includes some lean mass, and very low intake makes that worse. Our guide to protecting muscle on a GLP-1 covers why protein matters.
• Micronutrients. Eating very little for months raises the odds of running short on iron, B12, and other nutrients. See GLP-1 micronutrient gaps.
• Hydration. People who aren't hungry often forget to drink, too. The Wegovy label warns about acute kidney injury in people who became dehydrated from GI side effects.
• Blood sugar. If you also take insulin or a sulfonylurea, skipping meals on top of a GLP-1 raises low blood sugar risk.

Practical ways people handle it

These are eating strategies, not medication changes:

• Eat a protein-forward breakfast before your stimulant dose kicks in, when appetite is usually highest.
• Set meal reminders instead of waiting for hunger. Hunger cues may not show up reliably on both drugs.
• Keep easy protein on hand for the stimulant window: Greek yogurt, eggs, protein shakes, cottage cheese, tuna pouches.
• Plan a real evening meal as the stimulant wears off, but keep it moderate. Large, fatty meals are harder to tolerate on a GLP-1.
• Track intake for a week or two after starting or increasing either drug, so you have numbers to show your prescriber.

Heart rate and blood pressure

Both drug types raise resting heart rate a little on average. Here's what each label reports from its own trials:

It's tempting to add these numbers together. Don't treat the sum as a prediction. They come from separate trials in different populations, and no study has measured the combined effect. What's reasonable to say is that both push in the same direction, so a resting heart rate check at baseline and after each change makes sense.

The Adderall XR label also advises a careful cardiac history before starting stimulants, including any family history of sudden death or ventricular arrhythmia, and says stimulants should generally be avoided in people with serious structural heart disease, cardiomyopathy, serious arrhythmia, or coronary artery disease. Many people prescribed GLP-1s have cardiovascular risk factors, so it's worth making sure the stimulant prescriber knows about any heart history that has come up during your GLP-1 workup.

Symptoms to report

• A resting heart rate that stays noticeably higher than your usual, or a pounding or racing heartbeat at rest
• New palpitations or a sense of skipped beats
• Home blood pressure readings consistently above your usual range
• Lightheadedness, especially if you're also eating and drinking less

Absorption and timing changes

GLP-1 drugs slow the rate at which food and pills leave your stomach. Both the Wegovy and Zepbound labels say this can affect absorption of oral drugs and advise monitoring patients on oral medications that depend on reaching certain blood levels to work. The Zepbound label notes the delay is greatest after the first dose and lessens over time.

Extended-release stimulants are designed to release medication on a specific schedule as they move through the gut. Nobody has studied whether a GLP-1 changes that schedule. Some people might notice a later onset, a different peak, or a change in how long the dose lasts, especially early in GLP-1 treatment or after a dose increase. Others won't notice anything.

A separate wrinkle: the Adderall XR label says GI alkalinizing agents such as antacids increase amphetamine blood levels, and that proton pump inhibitors can shorten the time to peak concentration. Reflux and heartburn are common GLP-1 side effects, so if you start taking antacids or a PPI for GLP-1 reflux, tell your stimulant prescriber.

Sleep, anxiety, and GI side effects

Several side effects overlap or interact indirectly. Stimulants can affect sleep. GLP-1s can cause nausea that makes eating dinner harder, which can lead people to eat late or skip meals. Poor sleep and low food intake can both make ADHD symptoms and mood feel worse, which then gets blamed on the stimulant.

If you notice a shift in mood, anxiety, or sleep after starting a GLP-1, it's worth raising with both prescribers instead of assuming one drug is responsible. Our article on GLP-1s and mental health medications covers the broader picture.

What to tell each prescriber

If one clinician prescribes your stimulant and another prescribes your GLP-1, they may not see each other's notes. Don't assume they talk.

Tell your GLP-1 prescriber

• The stimulant name, formulation (immediate or extended release), and when you take it
• How much your appetite was already suppressed before starting the GLP-1
• Any heart rate or blood pressure history, and any cardiac testing you've had
• Any history of disordered eating. Two appetite suppressants together deserve extra caution in that setting.

Tell your stimulant prescriber

• That you started a GLP-1, which one, and your current dose stage
• Any change in how your stimulant seems to work: onset, peak, or duration
• Weight change since starting, and your typical daily food intake
• Any new antacid or PPI use
• Any new heart rate, blood pressure, sleep, or anxiety changes

A one-page medication list makes this much easier. Our medication list template shows what to include.

A practical checklist

1. Baseline numbers. Before starting the GLP-1, or as soon as you can, record a resting heart rate and blood pressure, ideally on a few different mornings.
2. Recheck after changes. Repeat those readings for a week after starting the GLP-1 and after each dose increase of either drug.
3. Eat by the clock. Use reminders, front-load protein, and don't rely on hunger to tell you when to eat.
4. Drink on a schedule. Especially on days with nausea, vomiting, or diarrhea.
5. Notice timing shifts. If your stimulant seems to kick in later or wear off differently, write down when and tell your prescriber rather than adjusting it yourself.
6. Keep both prescribers informed. Update each one at every visit, even if nothing seems wrong.